SCOTTSDALE, AZ USA (UroToday.com) - Dr. Raul Ordorica introduced Dr. Megan Bing, the 2013 Neuromodulation Award winner. Dr. Bing, of the University of Iowa, presented the results of her research that was sponsored by her 2013 award for “Sacral neuromodulation and cytokines: An investigation into interstitial cystitis.”
In this study, the patient mean age was 60, with a mean BMI of 35. Due to low patient accrual in patients with interstitial cystitis, eligibility was opened to all patients undergoing sacral neuromodulation. Urgency, frequency, and urge urinary incontinence were the most common indication (78%). Twenty-seven biomarkers were tracked after sacral neuromodulation implantation. O’Leary-Saint scores were assessed. Eotaxin was the only biomarker which showed a correlation with the O’Leary-Saint Score. Numerous urinary biomarkers were unable to be measured as they were too dilute. Current techniques are being developed to concentrate the biomarkers without affecting the accuracy of their detection.
Presented at the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) Winter Meeting - February 24 - 28, 2015 - JW Marriott Camelback Inn Resort & Spa - Scottsdale, AZ USA
Reported for UroToday by Drew Freilich, MD. Dr. Freilich is a graduate of the University of Massachusetts Medical School and completed his urology residency at New York Medical College/Westchester Medical Center. He is currently a fellow in Female Urology, Neurourology and Reconstructive Urology at Medical University of South Carolina. He has authored more than 40 peer-reviewed articles, monographs, abstracts, and book chapters and abstracts. Dr. Freilich is a member of the American Urological Association and the Society for Urodynamics and Female Urology.